Phillip C Delekta, Ingrid J Apel, Shufang Gu, Katy Siu, Yoshiyuki Hattori, Linda M McAllister-Lucas, Peter C Lucas
Index: J. Thorac. Cardiovasc. Surg. 285 , 41432-42, (2010)
Full Text: HTML
Thrombin is a potent modulator of endothelial function and, through stimulation of NF-κB, induces endothelial expression of intracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). These cell surface adhesion molecules recruit inflammatory cells to the vessel wall and thereby participate in the development of atherosclerosis, which is increasingly recognized as an inflammatory condition. The principal receptor for thrombin on endothelial cells is protease-activated receptor-1 (PAR-1), a member of the G protein-coupled receptor superfamily. Although it is known that PAR-1 signaling to NF-κB depends on initial PKC activation, the subsequent steps leading to stimulation of the canonical NF-κB machinery have remained unclear. Here, we demonstrate that a complex of proteins containing CARMA3, Bcl10, and MALT1 links PAR-1 activation to stimulation of the IκB kinase complex. IκB kinase in turn phosphorylates IκB, leading to its degradation and the release of active NF-κB. Further, we find that although this CARMA3·Bcl10·MALT1 signalosome shares features with a CARMA1-containing signalosome found in lymphocytes, there are significant differences in how the signalosomes communicate with their cognate receptors. Specifically, whereas the CARMA1-containing lymphocyte complex relies on 3-phosphoinositide-dependent protein kinase 1 for assembly and activation, the CARMA3-containing endothelial signalosome functions completely independent of 3-phosphoinositide-dependent protein kinase 1 and instead relies on β-arrestin 2 for assembly. Finally, we show that thrombin-dependent adhesion of monocytes to endothelial cells requires an intact endothelial CARMA3·Bcl10·MALT1 signalosome, underscoring the importance of the signalosome in mediating one of the most significant pro-atherogenic effects of thrombin.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
TRAP-6
CAS:141136-83-6 |
C34H56N10O9 |
Clinical effects of phosphodiesterase 3A mutations in inheri...
2015-10-01 [Hypertension 66 , 800-8, (2015)] |
Impact of variables of the P-selectin - P-selectin glycoprot...
2015-04-01 [Thromb. Haemost. 113(4) , 806-12, (2015)] |
Activated platelets present high mobility group box 1 to neu...
2014-12-01 [J. Thromb. Haemost. 12(12) , 2074-88, (2014)] |
Sex differences of leukocyte-platelet interactions and on-tr...
2014-12-01 [Atherosclerosis 237(2) , 692-5, (2014)] |
Pro-thrombotic effect of exercise in a polluted environment:...
2015-01-01 [Thromb. Haemost. 113(1) , 118-24, (2015)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved